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1. Introduction
Epigenetics is a mechanism that regulates gene expression not depending on the underlying
DNA sequence, but on the chemical modification of DNA and histone proteins. It is known
that several neurodevelopmental disorders are caused by congenital abnormalities in epige‐
netic mechanisms, including Prader-Willi and Angelman syndromes, which are genomic
imprinting disorders [1-3]. The advances in understanding of the epigenetic gene regulation
mechanisms and identification of proteins that participate in them have led to the identification
of other neurodevelopmental disorders, such as ICF and Rett syndromes, caused by mutations
in the genes that encode such proteins [4-8]. The discovery of Rett syndrome, a representative
autistic disorder caused by mutations in MECP2 that encodes an epigenetic regulatory protein,
introduced to us a new paradigm that neurodevelopmental disorders are not only caused by
mutations in the neuronal genes [9, 10], but also caused by abnormal epigenetic regulation of
the neuronal genes.
Several lines of evidence suggest that various environmental factors, such as nutrition (e.g.
folic acid and royal jelly), environmental chemicals, external electric stimuli to neurons, and
mental stress, can change epigenomic status, which supports the hypothesis that the epige‐
nome is more susceptible to environmental factors than the genome [11].
DNA methylation was initially believed to change gradually during the lifetime through
studies in cancer. However, it has recently been shown that DNA methylation can be altered
during the first week of life after birth in mice, and that the altered epigenomic status in the
brain is prolonged throughout the lifetime long with abnormal behavior [12]. It is also reported
that epigenetic changes can be induced by malnutrition during the fetal period, which
introduces the origin of adult diseases in the fetus in rats [13, 14]. Recent comparative studies
between monozygotic twins suggest that epigenomic changes also occur in humans [15, 16].
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Epigenetic is a reversible mechanism and thus, it has been accepted as a mechanism for
genomic imprinting in which the maternal expression pattern can be erased and reset to be the
paternal expression pattern when the imprinted gene is transmitted from the mother to the
offspring [17-20]. It has recently been shown that some drugs for mental disorders have an
effect on restoration of the epigenetic status and the expression pattern of the neuronal genes
based on this epigenomic reversibility [21-25]. It has also been reported that administration of
folic acid is effective in treating autistic children possibly by restoring DNA methylation status
at the disease-related gene regions [26-28]. Therefore, it is intriguing to think that advanced
“epigenomic drug” can be designed that only target to disease-specific gene regions using
recent technology such as pyrrole-imidazole polyamide [29, 30].
Epigenetics now challenge the biological dogma that “acquired nature cannot be transmitted
to the next generation”, because recent studies have shown that mental stress-induced
epigenomic changes cannot be completely erased at the stage of spermatogenesis and can be
transmitted to the third generation in mice [20, 31]. However, it is possible that appropriate
intervention such as drug, nutrition, and environmental condition can be restore the abnormal
epigenomic status and halt its inheritance, if such transmission is true in humans.
In this chapter, we present the epigenetic mechanisms that cause congenital disorders, show
examples of environmental factors that can alter the epigenetic status, and discuss recent topics
in epigenetics, such as strategies for the treatment of neurodevelopmental disorders utilizing
epigenetic reversibility and the possibility of its transgenerational inheritance.
2. Importance of proper gene regulation in the brain
The brain is a gene-dosage sensitive organ in which either under-expression or over-expression
of the same genes encoding proteins related to brain function results in a range of neurological
disorders. For example, Pelizaeus-Merzbacher disease, a severe congenital disease is caused
by either a deletion, mutation, or duplication of the proteolipid protein 1 (PLP1) gene [32].
Further, lissencephaly, a rare brain formation disorder, is caused by either deletion or dupli‐
cation of the platelet-activating factor acetylhydrolase 1B subunit alpha (PAFAH1B1) gene that
encodes a neuronal migration factor [33, 34]. Charcot-Marie-Tooth disease, an adult-onset
neuromuscular disease is caused by a mutation or duplication of the peripheral myelin protein
22 (PMP22) gene [35], and Parkinson’s disease is caused by a mutation or multiplication of the
α-synuclein (SNCA) gene [36]. These are all neurological disorders, and such examples have
not been observed in other clinical fields. Thus, these findings suggest that the brain is
extremely sensitive to perturbations in gene regulation, and further indicate that the brain is
an organ that requires a proper control system for gene expression.
Epigenetic mechanisms are one of the ways by which gene expression is controlled in higher
vertebrates. These mechanisms are essential for normal development during embryogenesis
[37], and for differentiation of neural cells [38] and other cell types [39]. Understanding of
epigenetic mechanisms, including DNA methylation, histone modification, and regulation by
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microRNAs, is important in elucidating the pathogenic pathways in neurodevelopmental
disorders [40-42].
3. Epigenetic mechanisms that cause congenital neurodevelopmental
disorders
Genomic imprinting is an epigenetic phenomenon that was initially discovered in humans and
mammals, which determines parental-specific monoallelic expression of a relatively small
number of genes during development. Imprinting must be logically imparted in the germ line,
where inherited maternal and paternal imprints are erased and new imprinting established
according to the individual’s sex (Figure 1) [17]. For example, before the maternal allele-specific
DNA methylation that contribute to monoallelic expression is established in a differential
methylated region 2 (DMR2) of mouse Igf2 gene, DMR2 is demethylated in both male and
female primordial gene cells (PGCs) by 13.5 days post coitum (dpc), indicating that the erasure
of imprinting in this region occurs earlier in PGC development [18]. Although DNA methyl‐
ation is the best established epigenetic mark that is critical for the allele-specific expression of
imprinted genes, many aspects of the regulation of DNA methylation are unknown, including
how methylation complexes are targeted and the molecular mechanisms underlying DNA
demethylation [19]. In this context, one mechanism related to genome-wide DNA demethy‐
lation to reset the epigenome for totipotency was recently revealed that erasure of CpG
methylation (5mC) in PGCs occurs via conversion to 5-hydroxymethylcytosine (5hmC), driven
by high levels of TET1 and TET2, and that global conversion to 5hmC is initiated asynchro‐
nously in PGCs at embryonic days (E) 9.5 to E10.5 for imprint erasure [20].
Figure 1. Erasure and establishment of genomic imprinting. Inherited maternal and paternal imprints are erased and
new imprinting established according to the individual’s sex during the process of spermatogenesis and oogenesis.
In an imprinted gene, one of the two parental alleles is active and the other is inactive due to
an epigenetic mechanism such as DNA methylation. Therefore, a defect in the active allele of
the imprinted gene results in the loss of expression. This has been found in the neurodeve‐
lopmental diseases, Prader-Willi syndrome and Angelman syndrome [2].
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The X chromosome has a large number of genes, whereas the Y chromosome has relatively
few. Thus, females (XX) have more genes than males (XY). To minimize this sex imbalance,
one of the two X chromosomes in females is inactivated by an epigenetic mechanism [3].
Improper X chromosome inactivation (XCI) is thought to be an embryonic lethal condition, as
suggested by the findings that a majority of aborted embryonic clones produced by somatic
nuclear transfer showed failure of XCI [43, 44], although it is difficult to directly demonstrate
failure of XCI in human aborted embryos. Even when failure of XCI occurs in women with
one normal X chromosome and a small X chromosome due to a large terminal deletion, and
thus the overdosage effect of X-linked genes is small, such affected women show severe
congenital neurodevelopmental delays [3], indicating that proper epigenetic gene suppression
is essential for normal development.
DNA methylation is a fundamental step in epigenetic gene control, and occurs by the DNA
methyltransferase (DNMT)-mediated addition of a methyl group (CH3) to CpG dinucleotides.
A defect in one of the DNMTs (e.g., DNMT3B) can cause a syndrome characterized by
immunodeficiency, centromere instability, facial anomalies (ICF), and mild mental retardation
[4-6]. Methyl-CpG-binding domain proteins (MBDs) are also important molecules in the
control of gene expression. Mutations in the methyl-CpG-binding protein 2 gene (MECP2),
one of the genes that encodes for MBD protein, can cause Rett syndrome, which is characterized
by seizures, ataxic gait, language dysfunction, and autistic behavior [7, 8]. Therefore, it is
thought that MeCP2 dysfunction leads to aberrant expression of genes in the brain associated
with neurological features of the disease. Recent studies have shown that MeCP2 controls a
subset of neuronal genes [45-48] or a potentially large number of genes [49], suggesting that
epigenetic dysregulation of multiple neuronal genes may cause neurological features of the
disease.
4. Environmental factors that alter the epigenetic status associated with
neurodevelopmental disorders
We have previously demonstrated that epigenetic instability at imprinting loci during the
process of finding proper methylation sites for diagnosis of Prader-Willi / Angelman syn‐
dromes, the epigenetic disorders described above [50]. In our study, the imprinted DNA
methylation status at the small nuclear ribonucleoprotein associated polypeptide N (SNRPN)
promoter region (e.g., maternally methylated and paternally unmethylated) in chromosome
15q12 was stable among various tissues such as lymphocyte, amniotic fluid cells, cultured
chorionic villus samples, various fetal tissues and Epstein-Barr virus lymphoblast cell lines
established from lymphocytes. However, at the PW71 locus adjacent to the SNRPN locus, the
imprinted methylation status was not consistent among these tissues. This indicates that
epigenetic status at the loci associated with neurodevelopmental disorders are susceptible to
environmental factors in vitro.
In neurodevelopmental disorders such as autism, both environmental factors (e.g., toxins,
infections) and genetic factors (e.g., mutations in synaptic molecules) have historically been
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discussed [51]. However, a biological mechanism that links these two groups of factors has not
been identified. Epigenetics may be the bridge between these factors, thereby contributing to
disease development [11]. Besides the intrinsic (congenital) epigenetic defects (associated with
disease as described above), several lines of evidence suggest that extrinsic (environmental)
factors, such as malnutrition [13, 14], drugs [21-25], mental stress during the neonatal period
[12], and neuronal stimulation [52], alter the epigenetic status and thereby affect brain function.
Therefore, it is intriguing to speculate that acquired neurodevelopmental disorders, including
autistic disorders, may be the result of epigenetic dysregulation caused by environmental
factors (Figure 2).
Figure 2. Current understanding of extrinsic mechanisms of neurodevelopmental disorders. Acquired neurodevelop‐
mental disorders are caused by extrinsic mechanism via various environmental factors.
Short-term mental stress after birth may alter the epigenetic status in the brain and result in
persistent abnormal behavior [12]. In rat pups from mothers exhibiting low levels of maternal
care, DNA methylation at the promoter of the glucocorticoid receptor gene (GR), which is also
known as the nuclear receptor subfamily 3 group C member 1 (NR3C1) gene, increased in the
hippocampus, which suppressed expression of the gene within the first week of life. In contrast,
promoter methylation decreased in the brains of the offspring with high maternal care during
the same period [12]. This paradigm was suggested to provide a putative animal model for
childhood neglect and maltreatment in humans. Postmortem analysis of the hippocampus of
suicide victims with a history of childhood abuse revealed the presence of hypermethylation
of the neuron-specific promoter of NR3C1 in combination with a decrease in its expression [53].
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This finding suggests that the adverse effects of early-life stress on DNA methylation may last
throughout life [54], and also indicates that neurodevelopmental problems may arise from
epigenetic dysregulation caused by environmental factors in early life.
Epigenetic mechanisms are also likely to be relevant to drug addiction. Gene expression in the
dopaminergic and glutamatergic systems is mediated by epigenetic mechanisms, and cocaine
and alcohol are known to alter the epigenetic state (e.g., cocaine induces either hyperacetyla‐
tion or hypoacetylation of histone H3 or H4 in the nucleus accumbens of mice, and alcohol
induces hyperacetylation of histones H3 and H4 in the frontal cortex and the nucleus accum‐
bens of adolescent rats), which may be associated with permanent behavioral consequences
[55, 56].
The findings above were mainly obtained in animal studies, and there is little evidence in
humans. However, the fact that epigenomic differences are larger in older monozygotic twins
than those in younger twins suggests that epigenetic status may be altered during aging by
environmental factors in humans [15]. Likewise, in monozygotic twins with discordant
severity of Rett syndrome, the epigenomic patterns and expression of neuronal genes have
been shown to differ [16]. This indicates that environmental factors may affect the human
epigenome and that epigenomic differences induced by environmental factors may contribute
to mental phenotypes.
Another phenomenon that may be related to epigenomic changes is the decline in birth weights
that has occurred during the past 20 years. This trend is thought to be a result of the popularity
of dieting among young women and of the recommendation by obstetric physicians to
minimize pregnancy weight gain in order to reduce the risk of gestational diabetes mellitus
[57]. Based on current epidemiological studies of populations affected by famines in the
Netherlands and China, the generation with lower birth weight is expected to have an
increased risk of not only metabolic disorders (e.g., obesity, diabetes mellitus) [58], but also
mental disorders [59]. This expectation is referred to as the Developmental Origin of Health
and Diseases (DOHaD) [60]. Recent studies have demonstrated that malnutrition during the
fetal period causes a hypomethylation imprint on the peroxisome proliferator-activated
receptor alpha (PPARa) gene in the rat liver [61]. Similar DNA methylation changes have been
identified in the peripheral tissues of people who suffered malnutrition during a period of
famine in the Netherlands [62]. It has also been reported that assisted reproductive technolo‐
gies (ART) (e.g., in vitro fertilization and intracytoplasmic sperm injection), which are now
widely used due to increases in maternal age, lead to decreased DNA methylation status at
multiple maternally methylated imprinted loci [63, 64]. Therefore, it is intriguing to think that
current social factors, such as DOHaD and ART, may be involved in the recent increase of
children with mild neurodevelopmental disorders in Japan and other countries [65-70] and
that epigenetic alteration may underlie this social phenomenon.
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5. Treatment of neurodevelopmental disorders by utilizing epigenetic
reversibility
It has been reported that administration of folic acid to pregnant rats alters the DNA methyl‐
ation status in the offspring [71]. Furthermore, folic acid supplementation in pregnant rats
under malnutrition conditions prevents hypomethylation of a hepatic gene in the offspring
[13]. In addition to folic acid, various environmental factors, such as royal jelly [72], drugs for
mental disorders [21, 23, 25], environmental chemicals [73, 74], and external stimuli (electro-
convulsive treatment for psychiatric diseases) [49], have also been reported to alter DNA
methylation and histone modification status in the brain and other organs in mice or other
species.
As mentioned above, mental stress in the first week of life causes epigenetic abnormalities in
the brains of mice. Conversely, several mouse studies have demonstrated that appropriate
educational conditions can ameliorate behavior abnormalities. Environmental enrichment
(EE), consisting of larger-sized home cages with a variety of objects including running wheels,
improved motor coordination and decreased anxiety-related behavior in heterozygous
Mecp2+/-female mice, a model of Rett syndrome [75, 76]. EE also improved locomotor activity
with reduced ventricular volume, and restored the expression of synaptic markers, such as
synaptophysin and PSD95 in the hypothalamus and syntaxin 1a and synaptotagmin in the
cortex of hemizygous Mecp2-/y male mice [77, 78].
It is generally thought to be difficult to cure patients with congenital mental disorders caused
by mutations that encode neuronal molecules, since it is difficult to distribute gene products
to the appropriate brain regions and at the appropriate time of brain development. However,
it was recently demonstrated that the epigenetic disorder Rett syndrome may be an exception,
partly because MeCP2 does not encode a product required for brain structure, but rather
encodes a “lubricant” that works at a relatively later period of brain development. As a
consequence, reintroduction of MECP2 into Mecp2 null mice not only before birth [79], but also
after birth, is sufficient to rescue Rett-like neurological symptoms [80]. Furthermore, restora‐
tion of MeCP2 function in astrocytes substantially improves locomotion, anxiety levels, and
respiratory abnormalities in hemizygous Mecp2-/Y male mice along with restoring dendritic
morphology [81]. These results suggest that up-regulation of MECP2, possibly mediated by
drug treatment, might help to improve brain function in Rett syndrome patients. Valproic acid,
one of the most popular drugs for epileptic seizure and a known HDAC inhibitor, increases
MeCP2 expression [82, 83], as well as fluoxetine, a drug for mental disorders, and cocaine [84].
Taken together, these results indicate that neurodevelopmental disorders caused by epigenetic
abnormalities can be treatable.
6. The possibility of transgenerational epigenetic inheritance
According to current understanding in the field of biology, one’s acquired character is not
inherited by the next generation of offspring. Based on this notion of Darwinian inheritance,
Current Understanding of Epigenomics and Epigenetics in Neurodevelopmental Disorders
http://dx.doi.org/10.5772/57534
83
bad habits acquired during one’s lifetime would not be transmitted to one’s children. However,
recent advances in epigenomics and epigenetics have revealed that such undesirable acquired
traits might be transmitted into the next generation.
Epigenetic marks, either DNA methylation or histone modifications, allow the mitotic
transmission of gene activity states from one cell to its daughter cells. A fundamental question
in epigenetics is whether these marks can also be transmitted meiotically through the germline.
In mammals, epigenetic marks should be cleared by demethylating factors such as the cytidine
deaminases (e.g., AID, APOBEC1) and re-established in each generation, but this clearing is
incomplete at some loci in the genome of several model organisms possibly due to deficiency
of demethylating factors (e.g. AID) [85]. A recent study has demonstrated rare regulatory
elements that escape systematic DNA demethylation in PGCs, providing a potential mecha‐
nistic basis for transgenerational epigenetic inheritance [20]. Therefore, based on this phe‐
nomenon, “transgenerational epigenetic inheritance”, which refers to the germline
transmission of an epigenetic mark [86, 87], may provide a direct biological proof for La‐
marckism, hypothesis suggesting the heritability of acquired characteristics.
It is important to draw a distinction between transgenerational epigenetic inheritance and
heritable germline epimutation. Transgenerational epigenetic inheritance is independent of
the DNA sequence, whereas heritable germline epimutation is a direct consequence of a cis-
acting epigenetic alteration, such as hypermethylation induced by an expansion of an unstable
CGG repeat within exon 1 of the Fragile X Mental Retardation Syndrome 1 gene (FMR1),
hypermethylation induced by a deletion in an adjacent gene within the promoter of the globin
gene, and hypermethylation induced by repetitive retrotransposons [87, 88]. Such specific-
sequence driven-epimutation is observed in an affected mother and son in a family with fragile
X syndrome, and it can be classified as a case of heritable germline epimutation [88]. This
inheritance pattern is also observed in other species, such as Caenorhabditis elegans. Therefore,
the heritability does not necessarily involve transgenerational epigenetic inheritance, as the
methylated state could be cleared on passage through the germline and could be re-established
according to a certain sequence during zygotic genome activation [88].
Transgenerational inheritance of epigenetic marks was first demonstrated in a specific mouse
strain. The methylation status at the Axin (Fu) locus in mature sperm, which reflects the
methylation state of the allele in the somatic tissue of the animal is linked to the shape of the
animal’s tail and does not undergo epigenetic reprogramming during gametogenesis [89].
Environmental factors, notably the fungicide vinclozilin, stress responses and nutritional
challenges, have been associated with transgenerational epigenetic inheritance in animal
models. However, it is often difficult to obtain direct evidence of transmission of epigenetic
marks per se from transmission of the exposure itself [90, 91]. Therefore, transgenerational
effects should be distinguished from parental and grandparental effects. In addition to
contributing to their DNA, parents can influence their offspring in many ways: for example,
by contributing bioactive molecules in the egg and sperm cytoplasm, and by providing
nutrients and hormonal information during embyogenesis. For example, malnutrition during
pregnancy does not only affect the pregnant mother and fetus but also the fetus’s primordial
germ cells, which can lead to phenotypic changes in the grandchildren (second generation).
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In one study, a specific diet (supplementation of folic acid) induced methylation at the Axin
(Fu) locus, which altered the hair color of the animals, and this alteration was inherited over
2 generations, but this status was lost by the third generation [92]. These findings indicate that
while a specific diet leads to parental and grandparental effects, the acquired epigenetic
information is not inherited transgenerationally, and that the Axin (Fu) locus is resistant to
environmentally induced acquisition of new germ-line epigenetic information [92].
Transgenerational effects of environmental toxins – namely, the endocrine disruptors vinclo‐
zolin (an antiandrogenic compound) and methyoxychlor (estrogenic compound)-have been
demonstrated in the fourth generation (F4) of rats resulting in decreased spermatogenic
capacity and increased male infertility, and the effects on reproduction correlate with altered
DNA methylation patterns in the germ line [93]. It has also been demonstrated that plastic-
derived endocrine disrupters, including bisphenol A, increase the risk of pubertal abnormal‐
ities, testicular diseases and ovarian diseases in the F3 generation of rats, and that differential
DNA methylated patterns were identified in the plastic-lineage F3 generation sperm in
comparison with control-lineage F3 generation sperm [94]. Therefore, “true” transgenerational
epigenetic inheritance up to third generation is suggested to exist in animals. This observation
has also been confirmed in Drosophila, in which an aberrant epigenetic mark (defective
chromatin state) acquired in one generation induced by environmental stress (e.g. heat shock)
was inherited by the next generation [95].
It has also been demonstrated that an aberrant epigenetic mark acquired in one generation by
mental stress (maternal separation in early life) can be inherited by the next generation (Figure
3, left) [31]. Chronic maternal separation alters behaviors as well as the profile of DNA
methylation in the promoter of several candidate genes in both the germline of the separated
mice and brains of the offspring with altered gene expression (e.g. decreases in the expression
of corticotropin releasing factor receptor 2 (Crfr2) in the amygdala and the hypothalamus) [31].
In this study, abnormal behavior was observed in the third generation, and altered DNA
methylation in the CpG islands of Mecp2, cannabinoid receptor-1 (Cb1), and Crfr2 were
observed in F1 sperm and F2 brain. It has also been reported that chronic maternal separation
increases cytosine methylation of the estrogen receptor (Er)-alpha1b gene promoter, indicating
that individual differences in maternal behavior are epigenetically transmitted from the
mother to her female offspring [96]. Further, the third generation of male rats upon exposure
to vinclozolin, a commonly-used fungicide, respond differently to chronic restraint (i.e.,
mental) stress during adolescence; they also show altered gene expression in the cortex and
CA1 regions of the brain, although direct epigenetic alteration (e.g., DNA methylation) has
not been confirmed [97]. These findings provide biological evidence suggesting that environ‐
mental factors, including traumatic experiences in early life, are risk factors for the develop‐
ment of behavioral and emotional disorders.
Environmental stress (e.g., maternal separation) in neonatal period induces epigenomic
changes in the brain and sperm in mice. The changes are transmitted to the next generation
along with abnormal behavior even when the offspring is reared by a normal mother. How‐
ever, it is possible to ameliorate these epigenetic changes by providing appropriate environ‐
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mental factors (e.g., nutrition, neuropsychiatric drugs or brain-stimulating enriched
environment).
Recent studies have suggested that epigenetic variations influenced by the environment occur
spontaneously and that the specific epigenetic pattern created is inherited over several
generations in plant populations. Understanding the emergence and heritability of epigenetic
variants is critical for understanding how they might become subject to natural selection and
thus affect genetic diversity [98]. In humans, clinical features can vary among family members
who share the same disease-causing mutation-a phenomenon referred to as variable expres‐
sivity; however, the precise molecular mechanism is not known. Therefore, it is intriguing to
speculate that the variable clinical expressivity is caused by the stochastic occurrence of
epigenetic variation during development [99] or by the spontaneous epigenetic changes during
the transmission to the next generation, as was observed in plants [98, 100].
It has been demonstrated that neuronal plasticity is determined by epigenetic plasticity, such
as chromatin remodeling and dynamic DNA methylation changes during brain development
[101, 102], and multiple lines of evidence that connect environmental factors to brain functions
via epigenetic regulation have been accumulating [21-25]. However, little is known as to
whether environment-induced epigenetic changes in the brain are transmitted to the next
generation along with abnormal brain functions, including mental disorders [31, 103].
Figure 3. Transgenerational abnormal epigenomic inheritance along with abnormal phenotype.
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In this context, whereas it is widely known that maternal nutrition and metabolism are critical
determinants of adult offspring health, recent reports describe adverse offspring outcomes
associated with the father's diet, indicating nongenetic inheritance of paternal experience [104].
Since the results of this study were interpreted as “you are what your dad ate” [105], we may
be able to interpret the results of studies of transgenerational epigenetic inheritance associated
with a specific mental state [31, 103] as “you are how your dad behaved”. Determining the
underlying mechanisms may require a reevaluation of our understanding of the heritability
of epigenetic states.
Based on the evidence described above, the readers of this chapter might draw the conclusion
that the field of epigenetics portends adverse news for society. However, if we are able to
identify a beneficial environment for human health in terms of epigenetics, it may be possible
to sever the environment-induced epigenetic patterns across the generation. Epigenetic
markings provide a "memory of past experiences"; these markings persist during the life span
of an individual and are transmitted to the offspring. Recent reports indicate that epigenetic
marks are a "memory of past experiences" that can be restored by taking advantage of the
reversibility of epigenetic modifications [106, 107]. Therefore, drug discovery and identifica‐
tion of beneficial condition to revert abnormal epigenetic modification may make it possible
to interrupt the negative chain reaction of transgenerational epigenetic inheritance and
promote better health in future generations (Figure 3, right).
7. Conclusion
The failure of epigenetic gene regulation is known to cause various rare congenital disorders.
However, this deregulation also cause common diseases that are induced by environmental
factors, since the epigenetic status is affected and changed by various environmental factors.
Furthermore, the altered epigenetic status in the genome can be transmitted to the succeeding
generations. Therefore, precise understanding of gene-environment interactions in light of
epigenomics and epigenetics is necessary, which will further our knowledge of neurodeve‐
lopmental disorders.
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